All In Biotech

Drug Trial Radar · NCT01174823

Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

Last checked: Nov 20, 2026Latest source record: Sep 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 245 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

245

Actual

Start

Jun 2010

Primary completion

Oct 2010

Study completion Dec 2010

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedIndustry
Sponsor type
Industry
First posted
Aug 4, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.

Conditions

  • Allergic Conjunctivitis

Interventions

  • bepotastine besilate ophthalmic solutionDrug

    sterile ophthalmic solution

  • placebo comparator ophthalmic solutionDrug

    sterile ophthalmic solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) - Mean Change in Total ScoreTime frame: Baseline, 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ISTA Pharmaceuticals, Inc.

    Irvine, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.